Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CONMED (CNMD)

CONMED to buy back $645.2 million of 2027 convertible notes for $637.2 million cash

Neutral Impact 4 of 5 financing Written later

On June 3, 2026, CONMED agreed in privately negotiated purchase agreements with certain holders to buy about $645.2 million of its 2.25% Convertible Senior Notes due 2027 for about $637.2 million in cash. The transactions are expected to close on June 15, 2026, subject to customary closing conditions, and would reduce the company's outstanding convertible debt.

Key points

  • Principal amount of notes to be purchased: approximately $645.2 million of 2.25% Convertible Senior Notes due 2027
  • Cash consideration: approximately $637.2 million
  • Agreements dated June 3, 2026, with certain holders of the notes in privately negotiated transactions
  • Expected closing date: June 15, 2026, subject to customary closing conditions

The filing

CompanyCONMED (CNMD)
Form8-K, current report
Filed with the SECJun 4, 2026, 7:30 AM ET
Accession number0001174947-26-000639

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.